← Leaderboards
George L Mutter
Brigham And Women'S Hospital
$1,977,946
Attributed
$1,977,946
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $394.6K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$1,977,946 · 2
By mechanism
R01$1,977,946 · 2
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Elizabeth A Stewart$4,734,535
- Jeffrey Sklar$6,561,305
- Bernard A. Rosner$14,721,069
- Meir J Stampfer$56,174,887
- Mark A. Rubin$21,732,421
Others in their field
Top investigators on “Cancer Risk”
- Gregory H Reaman · National Childhood Cancer Foundation$242,495,090
- David Heimbrook · Leidos Biomedical Research, Inc.$222,048,828
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Philip J Disaia · University Of California Irvine$144,085,463
- Mitchell D Schnall · University Of Pennsylvania$138,156,012
- Peter C Adamson · National Childhood Cancer Foundation$128,266,602
Research focus
Cancer RiskHistopathologyTumor Suppressor GenesProgesteroneFemaleNeoplasm /Cancer DiagnosisHuman SubjectClinical ResearchHormone TherapyDiagnosis Design /EvaluationNeoplasm /Cancer ChemotherapyNeoplasm /Cancer Classification /StagingUterus NeoplasmsPatient Oriented ResearchCancer PreventionPrognosisImmunocytochemistryBiopsyChemopreventionHysterectomyMorphometryImage ProcessingGenetic MarkersEarly Diagnosis
Grant awards (10)
Hormonal modulation of latent endometrial precancers$257,238
R01 · FY2008 · CA · contact PI
Hormonal modulation of latent endometrial precancers$257,238
R01 · FY2007 · CA · contact PI
Hormonal modulation of latent endometrial precancers$264,921
R01 · FY2006 · CA · contact PI
Biomarkers and Chemoprevention of Endometrial Cancer$120,366
R01 · FY2006 · CA · contact PI
Hormonal modulation of latent endometrial precancers$271,297
R01 · FY2005 · CA
Biomarkers and Chemoprevention of Endometrial Cancer$123,263
R01 · FY2005 · CA
Hormonal modulation of latent endometrial precancers$272,475
R01 · FY2004 · CA
Biomarkers and Chemoprevention of Endometrial Cancer$123,263
R01 · FY2004 · CA
Biomarkers and Chemoprevention of Endometrial Cancer$123,263
R01 · FY2003 · CA
Biomarkers and Chemoprevention of Endometrial Cancer$164,622
R01 · FY2002 · CA